With the ZIKV pandemic, the role of immunodominant protection of cross-reactive CD4+ and CD8+ T cells induced by primary DENV infection in secondary ZIKV infection has been described [13, 16, 17]. The gene discussed is CD8A; the disease is Zika virus infectious disease.